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LETTERS
In conclusion, this case 
indicates an unusual complication 
and condition in travel medicine 
with no straightforward diagnosis. 
However, it illustrates that TBRF 
should be systematically considered 
in the differential diagnosis of acute 
meningoencephalitis in travelers, even 
if microscopic results are negative, 
to prompt appropriate empirical 
treatment and molecular or serologic 
testing.
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To the Editor: Since 1999, 
several exanthematous vaccinia virus 
(VACV) outbreaks affecting dairy 
cattle and rural workers have been 
reported in Brazil (1,2). VACV, the 
prototype of the genus Orthopoxvirus 
(OPV), exhibits serologic cross-
reactivity with other OPV species and 
was used during the World Health 
Organization smallpox eradication 
campaign (3). The origin of VACV 
in Brazil is unknown, although some 
studies have suggested that VACV 
strains used during the campaign 
may be related to outbreaks of bovine 
vaccinia (BV) (2). In Brazil, BV affects 
the milk industry and public health 
services (1,2,4,5). During outbreaks, 
dairy cattle developed lesions on the 
teats and udders, causing a decrease in 
milk production (1,2,4,5). 
Another VACV subspecies, 
buffalopox virus (BPXV), has been 
isolated from buffaloes (Bubalus 
bubalis) in rural areas in India and 
causes clinical signs that resemble 
those seen during BV outbreaks in 
Brazil (6). Recent genetic analysis of 
BPXV samples confi rmed its close 
relationship to VACV-like viruses, 
although each virus has distinct 
genetic signatures (1,2,6). Until 
recently, buffalo herds have been 
almost exclusive to northern Brazil. 
However, the buffalo market has 
experienced great expansion in this 
country, and today, there are herds 
in all geographic regions of Brazil. 
These buffalo herds are hypothetically 
at risk for VACV infection, on the 
basis of the outbreaks caused by 
BPXV that have been described in 
India (6). To assess the risk for OPV 
infection in milk buffaloes in Brazil, 
we conducted a serosurvey of herds 
from southeastern Brazil, the region 
most affected by BV.
698 Emerging Infectious Diseases • www.cdc.gov/eid • Vol. 18, No. 4, April 2012
Table. Test results for 26-year-old woman who returned to Belgium from Senegal with 
meningoencephalitis complicating relapsing fever* 
Characteristic
Date and test result 
2010 Dec 21 2011 Jan 25 
Borrelia DNA in serum + for 16S rRNA and ITS4 genes – 
Borrelia DNA in CSF + (100% similarity to B. crocidurae flaB gene; 
GenBank accession no. GU357619) 
B. crocidurae IgM titer 25 0 
B. crocidurae IgG titer 400 400 
B. dutonii IgM titer 0 0 
B. dutonii IgG titer 200 200 
B. recurrentis – – 
B. burgdorferi – – 
*+, positive; ITS, internal transcribed spacer; –, negative; CSF, cerebrospinal fluid; fla, flagellin. 
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During October 2010, we 
screened milk buffalo herds in rural 
areas of Minas Gerais State, Brazil. 
Serum samples were collected from 
48 female buffaloes used for milk 
production; these animals belonged to 
3 neighboring properties in Carmo da 
Mata city (20°33′28″S, 44°52′15″W), 
which is in the same mesoregion 
where the VACV Passatempo virus 
strain was isolated during an outbreak 
in 2003 (5). Since then, several 
outbreaks have been reported in this 
area.
Serum samples were inactivated, 
and an OPV plaque-reduction 
neutralization test (PRNT) was 
performed (7). The serum titer was 
defi ned as the highest dilution that 
inhibited >70% of viral plaques 
relative to the level of inhibition of 
the negative controls. Samples also 
underwent ELISA for OPV IgG as 
described (4). Bovine serum samples 
were used as positive and negative 
controls (1,4). OPV-PRNT specifi city 
(98.4%) and sensitivity (93.5%) were 
confi rmed by using receiver-operating 
characteristic analysis as described 
(8). The tests were performed in 
duplicate.
Of the 48 buffalo serum samples, 
15 (31.25%) contained neutralizing 
antibodies against OPV; of these, 6 
(40%) had titers of 20, 5 (33.3%) had 
titers of 40, and 4 (26.6%) had titers 
>80 (Table). The ELISA yielded results 
similar to those of the PRNT; of the 48 
serum samples, 17 (35.41) were IgG 
positive (Table). A total of 14 samples 
were coincident in the PRNT and the 
ELISA, including most of those with 
high titers by PRNT. To detect viral 
DNA, we conducted nested PCR to 
amplify the viral growth factor gene 
(9) and real-time PCR to amplify the 
A56R gene (10); results were negative 
for all 48 serum samples.
We detected antibodies against 
OPV in buffaloes in Brazil 10 years 
after the fi rst reported VACV outbreak 
in cattle in southeastern Brazil (1). 
Because PRNT and ELISA indicate 
the presence of OPV antibodies in a 
nonspecifi c manner (OPV serologic 
cross-reaction), it was not possible to 
determine the species responsible for 
these results. However, seropositive 
buffaloes may have been exposed to 
VACV, the only OPV known to be 
circulating in Brazil (1,2,4,5,8).
The management of milk 
buffaloes in Brazil is similar to that of 
dairy cows, including manual milking 
(1,4,5). Cow milkers usually work on 
>2 farms, and the farm infrastructure 
commonly is unsophisticated (1,4,5). 
These conditions were shown to be 
favorable for the spread of VACV 
among cattle, which suggests that 
the same conditions could lead to the 
introduction of VACV into buffalo 
herds. Because some BV outbreaks 
are not reported by the farmers, it is 
not possible to know exactly how or 
when a buffalo herd in the study area 
was exposed to the virus. However, 
milkers who work with both cattle 
and buffalo may be a route of viral 
transmission, although other sources of 
exposure are possible (8). Although no 
exanthematous VACV outbreaks have 
been described in milk buffaloes in 
Brazil, our results suggest that buffalo 
herds may be exposed to VACV in 
BV-affected areas and therefore may 
be at risk for VACV infection. Further 
research is needed to determine 
routes of infection, including whether 
humans working as milkers contribute 
to virus transmission.
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Table. Results of testing for orthopoxvirus seropositivity in milk buffalo herds, Minas 
Gerais State, Brazil, October 2010* 
Test No. (%) samples 
PRNT  
 Total positive 15 (31.2) 
 Titer  
  20 6 (40.0) 
  40 5 (33.3) 
  80 2 (13.3) 
  160 2 (13.3) 
 Total negative 33 (68.7) 
ELISA
 Total positive 17 (35.4) 
 Total negative 31 (64.6) 
PRNT and ELISA positive 14 (29.2) 
*Serum samples were collected from 48 female buffaloes used for milk production. A positive titer 
was defined as the highest dilution that inhibited >70% of viral plaques relative to the level of 
inhibition of the negative controls. Samples also underwent ELISA for orthopoxvirus IgG as 
described (4). PRNT, plaque-reduction neutralization test. 
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New York and 
New Jersey, USA
To the Editor: Clinical 
infections with livestock-associated 
Staphylococcus aureus sequence type 
(ST) 398 have been reported in Europe, 
Canada, and the People’s Republic of 
China (1), as well as the Caribbean 
(2,3), and Colombia (4). Most reports 
describe infection with methicillin-
resistant S. aureus; relatively few 
describe infection with methicillin-
susceptible S. aureus (MSSA). In the 
United States, colonization of healthy 
adults by ST398 has been reported 
in Iowa (5) and in New York, New 
York (2); MSSA infections have been 
anecdotally reported in St. Louis, 
Missouri (6), and The Bronx, New 
York (7). We describe 8 infections with 
MSSA ST398 in the New York City 
area during a 7-year period (2004–
2010). Five infections with a related 
ST (ST291) from clonal complex 
(CC) 398 also were identifi ed. These 
fi ndings highlight the emergence 
of clinical infections with 2 distinct 
CC398 sequence types in the New 
York City area.
Retrospective typing of 4,167 
clinical S. aureus isolates from 
various studies involving inpatients 
and outpatients in the New York City 
area identifi ed 13 mecA-negative 
isolates with CC398-associated spa 
types (Table). Nine isolates were 
obtained from cultures of outpatients 
with skin and soft tissue infections; 
samples were submitted by physicians 
in the community. One isolate was 
associated with recurring skin and soft 
tissue infections in multiple body sites 
(BK21466); another was associated 
with genital infection (BK21732). Of 
the 4 ST398 isolates derived from 
bloodstream infections in hospitalized 
patients, 3 were recovered from 
intravenous drug users, 1 of whom 
died 1 day after admission for variceal 
bleeding (BK26722). Unlike the 
multidrug-resistant ST398 MSSA 
recently described in Colombia (4), 
most isolates in this study were 
susceptible to all antimicrobial drugs 
tested except penicillin, although 
several strains exhibited resistance to 
clindamycin and erythromycin. One 
isolate (BK23527) was submitted as 
oxacillin resistant (MIC ≈4 μg/mL) 
but lacked the mecA gene, which 
suggested that another mechanism 
was contributing to the resistance 
phenotype.
Multilocus sequence typing 
confi rmed 8 isolates as ST398 
(3–35–19–2–20–26–39); 5 isolates 
were assigned to ST291 (3–37–
19–2–20–26–32), a double-locus 
variant of ST398 (online Appendix 
Figure, panel A, wwwnc.cdc.gov/
EID/article/18/4/11-1419-FA1.htm). 
Most of the ST398 strains were spa 
type 109 (t571), described in MSSA 
carriage isolates from New York 
City (2) and MSSA infections from 
China (1), France (8), Martinique (3), 
the Dominican Republic (2,3), and 
Colombia (4). BURP (based upon 
repeat pattern) analysis clustered all 
of the spa types into spa-CC t571 
(online Appendix Figure, panel B); 
ST398 isolates clustered with spa type 
109 (t571), whereas ST291 isolates 
clustered with spa type 865 (t2313). 
Pulsed-fi eld gel electrophoresis was 
also performed on the 11 available 
isolates. Although the ST291 isolates 
were sensitive to digestion with SmaI, 
pulsed-fi eld gel electrophoresis was 
performed with Cfr9I to compare 
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